Journal
NATURE REVIEWS DRUG DISCOVERY
Volume 7, Issue 6, Pages 489-503Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nrd2589
Keywords
-
Funding
- NHLBI NIH HHS [R01 HL065405-02, R01 HL065405-08, R01 HL065405, R01 HL065405-07, R01 HL065405-04, R01 HL065405-01, R01 HL065405-09, R01 HL065405-03, R01 HL065405-06, R01 HL065405-05] Funding Source: Medline
Ask authors/readers for more resources
Lipids are vital components of many biological processes and crucial in the pathogenesis of numerous common diseases, but the specific mechanisms coupling intracellular lipids to biological targets and signalling pathways are not well understood. This is particularly the case for cells burdened with high lipid storage, trafficking and signalling capacity such as adipocytes and macrophages. Here, we discuss the central role of lipid chaperones-the fatty acid-binding proteins (FABPs)-in lipid-mediated biological processes and systemic metabolic homeostasis through the regulation of diverse lipid signals, and highlight their therapeutic significance. Pharmacological agents that modify FABP function may provide tissue-specific or cell-type-specific control of lipid signalling pathways, inflammatory responses and metabolic regulation, potentially providing a new class of drugs for diseases such as obesity, diabetes and atherosclerosis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available